Explore the expanding global market for chorionic gonadotropin for injection, driven by rising infertility and ART demand. Discover market s
Chorionic Gonadotropin for Injection, commonly known as human chorionic gonadotropin (hCG), is a hormone-based medication widely used in fertility treatments and reproductive healthcare. It plays a crucial role in helping individuals overcome infertility and improving the chances of successful conception.
hCG is a hormone naturally produced by the placenta during pregnancy and is responsible for supporting early pregnancy by stimulating hormone production and maintaining the uterine environment needed for embryo development.
In medical practice, chorionic gonadotropin injections are commonly used to induce ovulation in women who have difficulty releasing eggs naturally. The injection mimics the natural luteinizing hormone (LH) surge in the body, triggering the ovary to release a mature egg and increasing the likelihood of pregnancy.
These injections are also used in assisted reproductive technologies such as in vitro fertilization (IVF) and intrauterine insemination (IUI). In such treatments, the injection helps ensure that eggs mature and are released at the right time, improving the success rate of fertility procedures.
Beyond fertility treatments for women, hCG injections are used in men’s reproductive health to stimulate testosterone production and increase sperm production in certain cases of male infertility.
With the increasing prevalence of infertility, growing awareness of reproductive health, and advancements in fertility technologies, the chorionic gonadotropin for injection market is witnessing significant growth. Healthcare providers and fertility clinics worldwide continue to adopt these hormone therapies to support patients seeking effective reproductive solutions.
👉 Read the full report: https://www.trendvaultresearch.com/report/chorionic-gonadotropin-for-injection-69796
